Cynthia GERMANOS’ Post

This is one of the reasons I would love to work in the field of clinical trials. If there are 𝗻𝗼 𝗼𝘁𝗵𝗲𝗿 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗽𝘁𝗶𝗼𝗻𝘀 𝗹𝗲𝗳𝘁, you can provide new hope. Each patient deserves to be treated. Results like these, where 𝟯 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 are still undergoing treatment after more than a year (see at 5.13 min in the video) , show the potential of this combination therapy. Usually not common in 2nd line cancer clinical trials. 𝗞𝘂𝗱𝗼𝘀 and 𝗰𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 to the extremely talented Medivir AB Team!  𝗟𝘆𝗰𝗸𝗮 𝘁𝗶𝗹𝗹 for your 𝗽𝗵𝗮𝘀𝗲 𝟮𝗯 trial. #clinicaltrials #Livercancer #Oncologyresearch #Medicalinnovation #Biotech

Learn more about challenging clinical situations in the management of hematologic malignancies at the 28th Annual International Congress on Hematologic Malignancies from February 29 – March 3! Register: https://bit.ly/3PyEIZ9 #gotoPER #HEM24

Learn more about challenging clinical situations in the management of hematologic malignancies at the 28th Annual International Congress on Hematologic Malignancies from February 29 – March 3! Register: https://bit.ly/3PyEIZ9 #gotoPER #HEM24

Excellent presentations and in -depth discussions with experts in the HCC field at ESMO GI higlights the unmet medical need in 2nd line after progression on immune-therapy, and the potential of new modalitets such as fostrox

Join us for an insightful webinar hosted by Stago! 🔍 Title: Exploring the Fundamentals of Prothrombin Time (PT) / International Normalized Ratio (INR): A Time-Honored Global Coagulation Test 📅 Date: December 7, 2023   🕖 Time: 07:00 PM (Pakistan Time) Prothrombin Time (PT) and the International Normalized Ratio (INR) play a crucial role in assessing blood clotting ability, guiding clinical decisions, monitoring anticoagulant therapy, evaluating liver function, and diagnosing bleeding disorders. PT measures the time for blood to clot, reflecting the extrinsic and common coagulation pathways, while INR standardizes results for patients on antivitamin K therapy, such as warfarin. In this webinar, Prof. Armando Tripodi will share his expertise on the principles, indications, interpretation, and potential pitfalls of PT/INR. 🖊️ Register here: www.stagowebinars.com Happy learning! #MDSPL #Stago #Webinar #ProthrombinTime

Happening TODAY! Join the virtual event this year to explore sessions such as Managing #Cachexia in Clinical Practice, Equity in #Cancer Cachexia Trials & more. 🖇 https://lnkd.in/gvJA3iiR #Sarcopenia

Awareness is defined as “a concern about and well-informed interest”. Proud to raise awareness of AIHA and be part of J&J Innovative Medicine with commitment to pushing science forward. Especially today, I want those in the warm autoimmune hemolytic anemia (wAIHA) community to know they are seen and heard. #AIHAAwarenessDay #MyCompany #JNJImmunology

Are you coming to the 14th International Congress on Autoimmunity in Ljubljana, Slovenia? Be sure to visit us on booth # 1 and attend our industry session 💡“From Discovery to Clinical Practice: The Rise of Game-changing Autoimmune Biomarkers”. Scroll right for more details. We’re looking forward to seeing you there! #ICA2024 #Autoimmunity #Werfen #PoweringPatientCare #SpecializedDiagnostics

Getting ready for the 14th International Congress on Autoimmunity in Ljubljana, where we'll have a great representation of the Werfen Autoimmunity R&D team! Hope to see you at our industry session where some of the hot topics in autoimmune biomarkers will be discussed. #precisionmedicine #autoimmunity #biomarkers #autoantibodies

Innovations in healthcare often require fine tuning of the Healthcare System (HCS). This also applies to RadioLigand Therapies (RLT), a novel way of treating cancer patients, for which it's imperative that Healthcare System Stakeholders work together. 🎥 This Webinar will share what we've learned so far and what needs to happen to prepare HCS and to ensure patients have timely and equitable access to Radioligand Therapies #RLT Register below to hear from an exquisite panel of experts! 🔽